Newron Pharmaceuticals SpA

FSX:NP5.DE

8.87 (EUR) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income -16.962-17.472-14.884-19.618-20.162-15.019-5.301-15.204-24.983-10.723-7.713-2.497-6.437-21.673-24.351-16.356-11.089-16.401-14.919
Depreciation & Amortization 0.210.2020.2090.2190.2060.0470.0480.0330.0710.0330.0390.0630.0880.1490.5240.2710.21300
Deferred Income Tax 2.46000-5.11200.253-0.0597.421.9862.1230.6722.023.9743.262011.41900
Stock Based Compensation 0.1970.480.7621.4612.1262.1071.7392.2852.2511.230.8330.210.8420.0650.72100.62500
Change In Working Capital 1.5822-0.0963.730.5621.797-0.9510.1464.176-1.998-3.6517.152-0.686-0.3131.144-2.369-1.29300
Accounts Receivables 2.474-0.8951.8261.214-0.1623.0641.33-0.0090.598-1.2670.71800000000
Inventory 00.0880.1790.0470.0120.005-0.0010.0330.0630.201-0.0690.0130.15-0.0160.277-0.1350.82200
Accounts Payables 0.6030.585-4.1130.5510.723-1.221-2.2210.009-0.5980000000000
Other Working Capital -1.4952.2212.0121.918-0.012-0.051-0.060.1223.515-2.199-3.5827.139-0.836-0.2970.867-2.234-2.11500
Other Non Cash Items 1.9123.6982.564-1.380.17-5.04-4.192-6.784-1.797-0.526-2.3170.225-0.769-1.329-4.356-1.478-13.7416.7710.59
Operating Cash Flow -10.601-11.092-11.445-15.588-22.21-16.108-8.404-19.583-12.862-9.998-10.6865.825-4.942-19.127-23.056-19.932-13.866-9.63-14.329
Investing Activities:
Investments In Property Plant And Equipment -0.012-0.018-0.02-0.035-0.051-0.04-0.062-0.072-0.064-0.022-0.076-0.011-0.001-0.007-0.064-0.36-0.339-0.052-0.101
Acquisitions Net 00.299-8.440.0010.881000000.3019.971000-3.275000
Purchases Of Investments -1.026-3.04-1.698-2.215-3.0560-0.27500-6.9460000-1.6050000
Sales Maturities Of Investments 4.4312.74110.1381.6342.1753.00201.42.02600001.60200000.76
Other Investing Activites -0-0.2998.44-0.001-0.8810.0760.1190.1060.1230.1080.0010.0680.0660.0260.2252.022.5820.3010.097
Investing Cash Flow 3.394-0.3178.42-0.616-0.9323.038-0.2181.4342.085-6.860.22610.0280.0651.621-1.444-1.6152.2430.2490.756
Financing Activities:
Debt Repayment -0.192-0.186-15.632-7.42-17.908-0.154-0.364-0.362-0.36-0.359-0.357-0.35500000-0.0680
Common Stock Issued 000000.05123.80327.04829.09318.35608.59303.3516.55100.28766.63229.7
Common Stock Repurchased 000000-1.403000000000000
Dividends Paid 000000-1.403000000000000
Other Financing Activities -0.192-0.18630.46314.78535.4790.127-0.076-1.6-0.701-0.8090-0.2152.157-0.447-0.629-0.343-0.2720.1360
Financing Cash Flow -0.201-0.18614.8317.36517.5710.05121.9625.08628.03217.188-0.3578.0232.1572.9045.922-0.3430.01566.729.7
Other Information:
Effect Of Forex Changes On Cash 0.356000000000000000000
Net Change In Cash -7.052-11.59511.806-8.839-5.571-13.01913.3386.93717.2550.33-10.81723.876-2.72-14.602-18.578-21.89-11.60857.31916.127
Cash At End Of Period 6.34113.42425.01913.21322.05227.62356.28642.94836.01118.75618.42629.2435.3678.08722.68941.26763.15774.76517.446